Roxadustat Versus Epoetin Alfa for Treating Anemia in Patien

Significance Statement
Iron supplementation and erythropoiesis-stimulating agents (ESAs) are curr

Related Keywords

Australia , Japan , United States , United Kingdom , Nurminen , Southwest Finland , Finland , China , Helsinki , Eteläuomen Läi , London , City Of , Australian , James Sloand , Pconclusions Roxadustat , Jessica Gorrill , Pham Van , Vifor Relypsa , Lynda Szczech , Eli Lilly , Rachael Cazaly , Mary Beth Deyoung , Glaxosmithkline , Amgen , Reata Pharmaceuticals , Boehringer Ingelheim , Novartis , Pfizer , Astrazeneca , Kalbe International , Gilead Sciences , National Institutes Of Health , Cardiovascular Research Network , Nguyen Tri Phuong University Hospital Vietnam , International Council For Harmonisation Good Clinical Practice , Wales Bureau Of Health Information , Dialysis Center , Ethics Committee Or Institutional Review Board , Hope Dialysis Center , Kidney Health Australia , Walter Reed National Military Medical Center , Johnson , Elsevier , Fresenius Medical Care , Novo Nordisk , Efficacy Study , Treat Anemia , Patients With Chronic Kidney Disease , International Council , Harmonisation Good Clinical Practice , Human Biologic , Independent Ethics Committee , Institutional Review Board , Interactive Web Response System , Supplemental Table , Supplemental Appendix , Medical Dictionary , Regulatory Activities , Paramount Hope Dialysis Center , Cara Therapeutics , Corvidia Therapeutics , Megapro Biomedical , Unicycive Therapeutics , Otsuka Pharmaceutical , Merck Sharp , New South Wales Bureau , Health Information , Australian Organ Tissue , Transplant Authority , Research Network , Fresenius Medical Care Vifor , National Institutes , Aspire Learning , Nguyen Tri Phuong University Hospital , Walter Reed National Military Medical , Core Medica , Good Publication Practice , Perfect Agent , Anemia Management , Chronic Kidney Disease ,